MentionFox
Home › Stakes › Carisma Therapeutics Inc.
5%+ stakes · Schedule 13D and 13G

Carisma Therapeutics Inc.: 5%+ holders

Before you sign with, sell to or invest in Carisma Therapeutics Inc.

MentionFox check on Carisma Therapeutics Inc.: no red flags found in 5 sources; 1 item to note (checked 14 November 2026). mentionfox.com/c/stakes/carisma-therapeutics

  • Note: Layoff plan disclosed Dec 2024 (about 23 employees) (filing)

New since last check: Layoff plan disclosed Dec 2024 (about 23 employees) (filing, first seen 14 November 2026).

Check Carisma Therapeutics Inc. before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Carisma Therapeutics Inc.?

Who has reported owning 5% or more of Carisma Therapeutics Inc., from Schedule 13D and 13G filings: each holder's stake as filed, the timeline, and the purpose each 13D states, quoted.

As of November 14, 2026, Carisma Therapeutics Inc. has Schedule 13D or 13G filings on record, none whose latest reports a stake of 5% or more. 3 filings are on record since August 21, 2025 (Schedule 13D/A, September 2, 2025).

Sell to companies like Carisma Therapeutics Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Key facts

  • · Holder: HealthCap VII, L.P. · Percent: 0% · Shares: 0 · SCHEDULE 13D/A
  • · Holder: HealthCap VII, L.P. · Percent: 4.8% · SCHEDULE 13D/A
  • · Holder: HealthCap VII, L.P. · Percent: 6.5% · SCHEDULE 13D/A
At 5% or more0
Filings3
Latest filing2025-09-02

Carisma Therapeutics Inc. has 3 Schedule 13D or 13G filings on record since 2025-08-21. No holder's latest filing reports 5% or more. Each figure below is the holder's own, as filed, with the filing linked.

Layoffs on record: about 23 jobs, latest 2024-12-09 (layoff filings and notices).

Holders

HolderPercentSharesLatestEvent date
HealthCap VII, L.P.0%0SCHEDULE 13D/A, 2025-09-022025-09-02

Holding shares or following this stake? See who's behind Carisma Therapeutics Inc. and the warning signs.

Free to see. No signup.

Want the whole picture on Carisma Therapeutics Inc.?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Carisma Therapeutics Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Carisma Therapeutics Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    4 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Timeline

FiledHolderPercentFiling
2025-08-21HealthCap VII, L.P.6.5%SCHEDULE 13D/A
2025-08-29HealthCap VII, L.P.4.8%SCHEDULE 13D/A
2025-09-02HealthCap VII, L.P.0%SCHEDULE 13D/A

Tools for this story

Each opens in a new tab, filled in for Carisma Therapeutics Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

Cite this page

Permanent URL: https://mentionfox.com/stakes/carisma-therapeutics
Last updated 2026-11-14
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Who owns 5% or more of Carisma Therapeutics Inc.? Stakes filed. MentionFox, 2026-11-14. https://mentionfox.com/stakes/carisma-therapeutics